Article: Sustained benefit of combined dabrafenib/trametinib in patients with advanced melanoma

€3.03

SKU: product-article-11089 Category: General

Description
Reviews (0)

Description

Sustained benefit of combined dabrafenib/trametinib in patients with advanced melanoma

Reviews

There are no reviews yet.

Be the first to review “Article: Sustained benefit of combined dabrafenib/trametinib in patients with advanced melanoma”

You must be logged in to post a review.

Top

Article: Sustained benefit of combined dabrafenib/trametinib in patients with advanced melanoma

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in respiratory oncology

Article: Highlights in breast cancer

Article: INTRODUCTION